Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Antibacterial Market Survey: Analyses and ForecastsTechnology, Sales and Company Profiles ADIS, Nov 2002   Description     Table of Contents        Enquire before Buying    Send to a Friend   Over the past several years, infectious disease management has become an increasing challenge for practicing physicians. Management of bacterial infection has become difficult due to the emergence of drug-resistant bacteria. There has been an alarming increase in the number of resistant Gram-positive organisms over the last 5 years. These Gram-positive organisms include: Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecium, Enterococcus faecalis, and Streptococcus pneumoniae. Reports from several centralized agencies that follow bacterial resistance trends indicate that the prevalence of methicillin-resistant S. aureus (Mrsa) has increased from 25 to 37% and vancomycin-resistant E. faecium (VRE) from 35 to 65% in the last 3 years alone. These resistant organisms represent a major cause of morbidity and mortality in hospitalized patients with infections. The problem of resistant Gram-positive organisms is not limited to the hospitalized patient. Outpatients have also been affected with the emergence of penicillin-resistant S. pneumoniae (Prsp), a cause of community-acquired pneumonia. Customers who bought this item also bought Antibacterial: Drug Licensing Opportunities, 2002 Gastric Relief Rx-to-otc Switch US Market Survey: Revised Analysis and Forecast - Technology, Sales and Company Profiles Licensing in Antibacterial R&D - Filling the Gaps Strategic Perspectives: The Hospital Antibacterial Market - Defining a Sector Specific Strategy Strategic Perspective 2001: The Hospital Antibacterial Market - Economic Constraints Drive Development of Niche Products Stakeholder Insight: The Hospital Antibacterial Market - Specialist Products Drive Market Growth ADME in Children and The Elderly: Clinical Challenges and Opportunities Respiratory Therapy European Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster